Evelyn Gitau | |
---|---|
Born | Kenya |
Alma mater | Open University, Liverpool School of Tropical Medicine |
Awards | Next Einstein Fellow |
Scientific career | |
Fields | Immunology, cellular immunology |
Institutions | African Academy of Sciences, African Population and Health Research Centre |
Thesis | Changes in protein levels as markers of severe disease: an investigation of severe malaria (2008) |
Evelyn Nungari Gitau is a Kenyan cellular immunologist at the African Academy of Sciences, and was named a Next Einstein Fellow.
Gitau grew up in the Dagoretti area of Nairobi, Kenya. [1] [2] She attended The Kenya High School from 1990 to 1993, where she developed a passion for chemistry, [3] and would spend her free time at the chemistry lab at the University of Nairobi where her best friend's father was the head of the Chemistry department. [4] After graduating high school, she was selected for the inaugural medicine class at Moi University but chose to study chemistry instead. [4]
In 2002, Gitau, joined the KEMRI-Wellcome Trust Programme as a Research Assistant in Pharmacology. [2] The KEMRI-Wellcome Trust Programme-Kenya then sponsored her doctoral degree in cellular immunology at the Open University in the UK, in collaboration with the Liverpool School of Tropical Medicine. [5] Gitau's doctoral research investigated neurological infections in children living in malaria-endemic areas, [6] specifically, how changes in protein levels could be used to detect severe disease. Gitau compared the proteins in the plasma and cerebrospinal fluid of children with cerebral malarial to those in children with other encephalopathies. [2]
Gitau returned to Kenya in 2007 to work as a post-doctoral assistant in Kilifi. There, she investigated the cellular immune responses to the P. falciparum malaria. Gitau's research examines how cerebral malaria affects cells, specifically in children, and has led internationally competitive research on the subject. [7] Samples were initially frozen and shipped to Kenya from the United Kingdom, but Gitau was concerned that this processing could affect her research, so she lobbied for the purchase of much-needed equipment in her lab. [3]
Gitau's research emphasised how severe malnutrition often overlapped with severe malaria and other childhood infections: children who were severely undernourished were more likely to die from preventable infections. [2] In 2013, as a postdoctoral researcher at the KEMRI-Wellcome Trust Research Programme (KWTP), she received a "Stars in Global Health" seed grant worth $100,000 from the competitive Grand Challenges Canada, supported by the Canadian government. The grant supported her research to develop a simple blood test for severe malnutrition and common infections. [8] [9] [7] [3]
Gitau served as the African Academy of Science's Programme manager for the Alliance for Accelerating Excellence in Science in African (AESA). [3] In this capacity, she set up the Grand Challenges Africa initiative, raising over $11 million, and oversaw the implementation. The initiative, supported by the Bill and Melinda Gates Foundation, funds projects working to achieve the Sustainable Development Goals led by innovators from African countries. [4] She stepped down from this role on 31 October 2017, but continues to support the initiative in an advisory capacity. [10]
Gitau is the Director of Research Capacity Strengthening at the African Population and Health Research Center, contributing to its signature programme: the Consortium for the Advancement of Research Training in Africa (CARTA). [6] She serves on numerous advisory boards including the Independent Scientific Advisory Board (ISAB), the Malawi-Liverpool-Wellcome Trust Clinical Research Programme College of Medicine, the Investment Committee Grand Challenges Canada, [6] and the Crick-Africa Network. [11] Gitau also participates in a mentorship program in Kenya that aims to encourage more women to study science by pairing young girls with high school science students on science projects. [3]
In 2015, Gitau was named as a fellow of the Next Einstein Forum, which aims 'to create the right environment for the next Einstein to emerge from Africa'. [3] She is the ambassador for the development of Science, Technology, Engineering and Mathematics in Africa. [6]
Gitau was also on the Quartz Africa Innovators 2016 List, which highlights innovators for their "groundbreaking work, thought-leading initiatives and creative approaches to problems." [7]
The Wellcome Trust is a charitable foundation focused on health research based in London, in the United Kingdom. It was established in 1936 with legacies from the pharmaceutical magnate Henry Wellcome to fund research to improve human and animal health. The aim of the Trust is to "support science to solve the urgent health challenges facing everyone." It had a financial endowment of £29.1 billion in 2020, making it the fourth wealthiest charitable foundation in the world. In 2012, the Wellcome Trust was described by the Financial Times as the United Kingdom's largest provider of non-governmental funding for scientific research, and one of the largest providers in the world. According to their annual report, the Wellcome Trust spent GBP £1.1Bn on charitable activities across their 2019/2020 financial year. According to the OECD, the Wellcome Trust's financing for 2019 development increased by 22% to US$327 million.
Kilifi is a town on the coast of Kenya, 56 kilometres (35 mi) northeast by road of Mombasa. The town lies on the Kilifi Creek and sits on the estuary of the Goshi River. Kilifi is capital of the Kilifi County and has a population of 122,899.
The Kenya Medical Research Institute (KEMRI) is a state corporation established through the Science and Technology (Amendment) Act of 1979,, during the tenure of Nicholas Biwott as Minister of State, as the national body responsible for carrying out health research in Kenya.
Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.
The Royal Society Africa Prize has been awarded by the Royal Society since 2006 to African-based researchers at the start of their career who are making innovative contributions to the biological sciences in Africa. £60,000 is awarded as a grant for the recipient to carry out a research project that is linked to an African centre of scientific excellence, normally a University or equivalent research centre, and a further £5,000 is given directly to the prizewinner.
Julie Makani is a Tanzanian medical researcher. From 2014 she is Wellcome Trust Research Fellow and Associate Professor in the Department of Haematology and Blood Transfusion at the Muhimbili University of Health and Allied Sciences (MUHAS). Also a visiting fellow and consultant to the Nuffield Department of Medicine, University of Oxford, she is based in Dar es Salaam, Tanzania. In 2011, she received the Royal Society Pfizer Award for her work with sickle cell disease.
Peggoty Mutai is a Kenyan chemist. Born in Kericho, her interests include medicinal chemistry, in particular working with the search for new treatments against parasitic worms.
The Malaria Eradication Scientific Alliance (MESA) is an organization founded on the research carried out by the Malaria Eradication Research Agenda (malERA). "malERA" was a project carried out by the scientific community to identify the steps and future research that must be done in order to eradicate malaria. It was created after the Malaria Forum in 2007, hosted by the Bill and Melinda Gates Foundation, reestablished malaria eradication as a long-term goal. "malERA" first launched in 2008, and resulted in a research and development agenda which was published in a PLoS Medicine magazine in 2011. MESA was formed in 2012 to continue the goals of malERA through research and development of methods to fight malaria.
Faith Hope Among’in Osier is a Kenyan immunologist, paediatrician and educator.
Amina Abubakar is a Kenyan associate Professor of Psychology and Public Health at Pwani University. She is a research fellow at the Kenya Medical Research Institute. Her research considers the developmental delay in children who have HIV, malnutrition and malaria. She is an honorary fellow at the University of Oxford.
Thomas M. Kariuki is a Kenya biologist who is Chief Executive Officer of the Science for Africa Foundation. Kariuki previously served as the Director of Programmes for the Alliance for Accelerating Excellence in Science in Africa (AESA). He was the Director of the Institute of Primate Research/National Museums of Kenya, for seven years. Kariuki’s research interests have spanned the immunology of neglected infectious diseases and he has been involved in global efforts to develop vaccines, drugs and diagnostics for poverty-related diseases. He has published on vaccines and diagnostics development for schistosomiasis (Bilharzia), malaria and co-infections and on policy issues related to biomedical research and funding. He is a Fellow of the African Academy of Sciences (AAS), Senior Fellowship of the European Foundations Initiative for Neglected Tropical Diseases, Presidential honour of the Order of Grand Warrior of Kenya (OGW) for scientific leadership and public service, Honorary Professor of Research of the Liverpool School of Tropical Medicine, LSTM.
Fredros Okumu is a Kenyan parasitologist and entomologist, who currently works as director of science at the Ifakara Health Institute (IHI) in Tanzania. His primary research interests concern the interactions between humans and mosquitoes.
Tolullah "Tolu" Oni is a Nigerian urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge. She is a NextEinstein Forum Fellow and World Economic Forum Young Global Leader.
Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.
Kathryn Maitland is a British paediatrician who is professor of infectious diseases at Imperial College London, director of the ICCARE Centre at the Institute of Global Health Innovation and an Honorary Fellow at Medical Research Council Clinical Trials Unit, University College, London. Since 2000 she has been based at the KEMRI-Wellcome Trust Research Programme, in Kilifi, Kenya.
Marta Tufet Bayona is a British and Spanish biologist and public health resource coordinator with a specialty in malaria. She is executive director of the UK Collaborative on Development Research.
Kevin Marsh is a British Malariologist, academic and a researcher. He is a Professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.
Sanjeev Krishna,, is a British physician and parasitologist whose research focuses on affordable diagnosis and treatment of diseases such as COVID-19, malaria, Ebola, African trypanosomiasis, leishmaniasis, and colorectal cancer. Krishna is Professor of Medicine and Molecular Parasitology at St George's, University of London and St George's Hospital.
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is an international research initiative based in Oxford, England. It is hosted at the Nuffield Department of Medicine within the University of Oxford and led by the Epidemic diseases Research Group Oxford (ERGO). ISARIC is funded by the Bill & Melinda Gates Foundation, Foreign, Commonwealth and Development Office, and Wellcome Trust.
Emelda Aluoch Okiro is a Kenyan public health researcher who is lead of the Population Health Unit at the Kenya Medical Research Institute–Wellcome Trust program in Kenya. She looks to understand the determinants of health transitions and to evaluate access to health information. She is a Fellow of the African Academy of Sciences.
{{cite web}}
: |last=
has generic name (help)